Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Death And Tax Inversion: Policy Fight Won't Go Away, Now Spawning Lawsuits

Executive Summary

US Chamber of Commerce wants court to eliminate IRS rule that blocked Pfizer's acquisition of Allergan; AbbVie hit with second suit over its 2014 proposed acquisition of Shire.


Related Content

US Treasury’s Final Earnings Stripping Guidance Keeps Pressure On Inversions
With The End Of Pfizergan, Pfizer Has To Grow It Alone
US Treasury Hits Back On Inversions; Will Pfizer Fold?
Deal Watch: AbbVie Cancels Shire Buyout, Blaming U.S. Tax Policy Revisions


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts